510(k) Report

510(k) · Cleared

Cleared

QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph (QCARD-10W)

K260250510(k) TraditionalCleared Sep 29, 2026245-day reviewClass II21 CFR 870.2340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

QT Medical, Inc. · DPS Electrocardiograph

Cleared on Sep 29, 2026 as substantially equivalent to K120865 (Mortara Instrument, Inc., 2012) after a 245-day review. Its family tree reaches back 5 generations to 1994.

Decided
Sep 29, 2026
Review
245 days
Class
Class II
Product code
DPS
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K933143 (1994). 10 ancestors in all, the oldest K920626 (1992). No later device cites it as a predicate yet.

  1. Root · 5 generations backK933143 Model Eli 300 ElectrocardiographMortara Instrument, Inc. · 1994
  2. 4 generations backK062677 Eli 350 ElectrocardiographMortara Instrument, Inc. · 2006
  3. 3 generations backK082946 Mortara Eli 350 ElectrocardiographMortara Instrument, Inc. · 2008
  4. 2 generations backK093339 Eli PC ElectrocardiographMortara Instrument, Inc. · 2010 · Recalled
  5. 1 generation backK120865 Rscribe ElectrocardiographMortara Instrument, Inc. · 2012 · Recalled
  6. This deviceK260250 QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph…QT Medical, Inc. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K933143Model Eli 300 ElectrocardiographMortara Instrument, Inc.1994—
−4K062677Eli 350 ElectrocardiographMortara Instrument, Inc.2006—
−3K082946Mortara Eli 350 ElectrocardiographMortara Instrument, Inc.2008—
−2K093339Eli PC ElectrocardiographMortara Instrument, Inc.20101
−1K120865Rscribe ElectrocardiographMortara Instrument, Inc.20121
0 (this device)K260250QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph (QCARD-10W)QT Medical, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199710
200010
200310
201010
FIG. 1 — Lineage of K260250, 1994–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DPS device

  1. #1 K212112 Cardiologs Holter Platformscore 18.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120865Rscribe Electrocardiograph
Summary page 5
…RANSDUCER AND ELECTRODE, PAj I Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K120865 RScribe Electrocardiograph DPS Device Description Summary 21 CFR 807.92(a)(4) # Purpose and Use: Non-invasive, prescription 12-…
Mortara Instrument, Inc.20121

Also cleared against K120865: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 2 companies; a new generation was cleared every 2.4 years on median.
  • 4 of the 10 ancestors have a recall of any class.
  • 1 other device also cites its predicate K120865.

How does its category compare?

All DPS devices

DPS Electrocardiograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · DPS

6in 2025

2007: 112008: 132009: 142010: 112011: 222012: 122013: 102014: 112015: 82016: 112017: 92018: 142019: 32020: 62021: 52022: 62023: 102024: 82025: 62026 (partial year): 6
2007high 22 (2011) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DPS

163in 2025

2007: 87 days median2008: 31 days median2009: 84 days median2010: 104 days median2011: 154 days median2012: 117 days median2013: 134 days median2014: 253 days median2015: 178 days median2016: 229 days median2017: 177 days median2018: 221 days median2019: 178 days median2020: 224 days median2021: 135 days median2022: 244 days median2023: 236 days median2024: 260 days median2025: 163 days median2026 (partial year): 258 days median
2007high 260 (2024) · low 31 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DPS

3in 2025

2007: 22009: 12010: 22011: 12019: 92020: 22021: 12022: 12023: 32024: 4, 1 Class I2025: 32026 (partial year): 4
2007high 9 (2019) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · DPS

55in 2025

2007: 92008: 172009: 142010: 212011: 1212012: 562013: 152014: 152015: 302016: 122017: 152018: 192019: 272020: 592021: 242022: 592023: 542024: 642025: 55
2007high 121 (2011) · low 9 (2007)2025

MAUDE reports naming product code DPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007118729
20081331017
20091484114
201011104221
2011221541121
201212117056
201310134015
201411253015
20158178030
201611229012
20179177015
201814221019
20193178927
20206224259
20215135124
20226244159
202310236354
202482604 (1)64
20256163355
202662584—

What is it indicated for?

The QCA 10/10W ECG System is a non-invasive prescription medical device intended for use by trained healthcare professionals in clinical settings (e.g., hospitals, medical clinics, physician offices). The device is intended to acquire, record, display, analyze, store, and print 12-lead ECG signals from both adult and pediatric patients (pediatric: >1 month to 21 years of age). The analysis function provides basic automated ECG measurements.

The device is not intended for use as a vital signs physiological monitor.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260250: QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph (QCARD-10W).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260250

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026